Skip to main content
Clinical Trials/NCT02147769
NCT02147769
Completed
Not Applicable

Cerebral Oxygenation and Autoregulation in Preterm Infants: Association With Morbidity and Mortality

Stanford University7 sites in 1 country111 target enrollmentMay 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Intraventricular Hemorrhage of Prematurity
Sponsor
Stanford University
Enrollment
111
Locations
7
Primary Endpoint
Mortality Before Hospital Discharge
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Premature infants are at high risk for variations in blood pressure and oxygenation during the first few days of life. The immaturity of the premature brain may further predispose these infants to death or the development of neurologic problems. The relationship between unstable blood pressure and oxygen levels and brain injury has not been well elucidated.

This study investigates the utility of near-infrared spectroscopy (NIRS), a non-invasive oxygen-measuring device, to identify preterm infants at highest risk for brain injury or death.

Registry
clinicaltrials.gov
Start Date
May 2014
End Date
March 2018
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Valerie Chock, M.D., M.S. Epi

Principle Investigator

Stanford University

Eligibility Criteria

Inclusion Criteria

  • birth weight \<= 1250 grams
  • indwelling arterial catheter in place
  • age \<24 hours old

Exclusion Criteria

  • lethal chromosomal abnormality
  • major congenital anomaly
  • skin integrity insufficient to allow placement of NIRS sensors
  • decision to not provide full intensive care

Outcomes

Primary Outcomes

Mortality Before Hospital Discharge

Time Frame: Outcome measure will be assessed at the time of subject's initial discharge from the hospital (on average by 40 weeks postmenstrual age), but at a maximum of 1 year of life.

Participants will be followed for the outcome of death prior to hospital discharge.

Severe Central Nervous System (CNS) Morbidity

Time Frame: Outcome measure will be assessed on day 10 of life. Participants will be followed for neuroradiographic evidence of CNS morbidity in the first ten days of life

Routine cranial ultrasound obtained within the first ten days of life will be utilized to detect grade 3 or 4 intraventricular hemorrhage, periventricular leukomalacia, significant ventriculomegaly, or white matter abnormalities.

Study Sites (7)

Loading locations...

Similar Trials